Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 23,556 shares at $12.35 ($290K) on 2021-03-25, disclosed to the SEC on 2021-03-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.35 | 10,036 | $124K | 42.7% |
| 2 | $12.35 | 10,036 | $124K | 42.7% |
| 3 | $12.15 | 3,484 | $42K | 14.6% |
| Total | $12.32 avg | 23,556 | $290K | 100% |
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-31 | $741K | — | Filing → |
| CMPI | BUY | 2021-01-28 | $22K | — | Filing → |